Assenagon Asset Management
SURF

Assenagon Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Assenagon Asset Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,821
Closed -$135K – 1623
2022
Q1 		$135K Buy
+45,821
New +$161K ﹤0.01% 1372
2021
Q2 		– Sell
-25,371
Closed -$198K – 1462
2021
Q1 		$198K Buy
+25,371
New +$254K ﹤0.01% 1154
2020
Q4 		– Sell
-20,283
Closed -$140K – 1308
2020
Q3 		$140K Buy
20,283
+3,521
+21% +$21.4K ﹤0.01% 1085
2020
Q2 		$110K Buy
+16,762
New +$60.5K ﹤0.01% 1087

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assenagon Asset Management's SURF Position: Q2 2022 in Review

Assenagon Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 45,821 shares — an estimated $135K sold.

Assenagon Asset Management first reported a position in SURF in Q2 2020 and held it in 4 quarters. The position peaked at $198K in Q1 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • Assenagon Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 45,821 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $135K.
  • Assenagon Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Assenagon Asset Management's Surface Oncology, Inc. Common Stock position peaked at $198K in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.